HIV increases mean platelet volume during asymptomatic HIV infection in treatment-naive patients

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 5, 2011, Pages

  Mena, Álvaro ^a   Meijide, Héctor ^a   Vázquez, Pilar ^a   Castro, Ángeles ^a,b   López, Soledad ^a   Bello, Laura ^a   Serrano, Joaquín ^a   Baliñas, Josefa ^a   Pedreira, José D ^a,b  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VIRUS DNA;

ADULT; CD4+ T LYMPHOCYTE; CIGARETTE SMOKING; FEMALE; HEPATITIS B; HEPATITIS C; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LETTER; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MIXED INFECTION; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; BLOOD GLUCOSE; BLOOD PLATELETS; CD4 LYMPHOCYTE COUNT; CELL SIZE; FEMALE; HEPATITIS B; HEPATITIS C; HIV; HIV INFECTIONS; HUMANS; LIPIDS; MALE; PLATELET COUNT; RETROSPECTIVE STUDIES; RNA, VIRAL; SMOKING;

EID: 80051481294     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182243720     Document Type: Letter

References (9)

1. El Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283-2296. (Pubitemid 44837777)
2. Kuller LH, Tracy R, BellosoW, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5:e203.
3. Ananworanich J, Gayet-Ageron A, Le Braz M, et al. CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomized trial. Lancet. 2006;368:459-465. (Pubitemid 44142768)
4. Baker JV, Neuhaus J, Duprez D, et al. Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection. J Acquir Immune Defic Syndr. 2011;56:36-43.
5. Calmy A, Gayet-Ageron A, Montecucco F, et al. HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial. AIDS. 2009;23:929-939.
6. Van der Loo B, Martin JF. A role of changes in platelet production in the cause of acute coronary syndromes. Arterioscler Thromb Vasc Biol. 1999;19:672-679. (Pubitemid 29135170)
7. Klovaite J, Benn M, Yazdanyar S, et al. High platelet volume and increased risk of myocardial infarction: 39,531 participants from the general population. J Thromb Haemost. 2011;9:49-56.
8. Berger JS, Eraso LH, Xie D, et al. Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey, 1994-2004. Atherosclerosis. 2010;21:586-591.
9. Ross AC, Armentrout R, OíRiordan MA, et al. Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy. J Acquir Immune Defic Syndr. 2008;49:499-506.